Please login to the form below

PulmoBioMed Wins National Life Science Competition

Newly launched Northumbria University spinout PulmoBioMed has been handpicked as the winners of Onyx Health's ThinkBig competition

Healthcare marketing communications agency, Onyx Health, have chosen innovative MedTech spinout PulmoBioMed as the winner of their £5,000 #ThinkBig competition, designed to help life science companies bounce back from the COVID-19 crisis.

Having been chosen as the lucky winner of the competition, PulmoBioMed will receive £5,000 of Onyx Health’s full range of specialist healthcare communications support for free, helping them achieve commercial success and access key target markets. #ThinkBig is aimed at innovative start-ups and SMEs in the health and life science sectors, who are at the cutting edge of the industry and can bring something distinctive to the market.

PulmoBioMed is a newly launched Northumbria University spinout, founded by Associate Professor Dr Sterghios Moschos and supported into commercialisation by Chief Executive Officer Dr Pete Hotten, who has over 20 years of senior management experience.

Dr Moschos’s pioneering work in biomedical sciences and proof of concept funding from Northern Accelerator has led to the creation of an innovative, hand-held breath testing device PBM-Hale™. The device allows sampling of the lungs in a non-invasive way which can be used to detect biomarkers in the breath, for lung conditions such as COVID-19, therapeutic drugs and substances of abuse. This potentially ground-breaking technology is currently being trialled in clinical centres across Europe, with exciting results expected soon.

Onyx Health Associate Director Louise Flintoft said, "We had a strong field of entries from across the UK and Europe for our #ThinkBig competition, and from diverse areas of Medical Diagnostics and Devices, Biotechnology and Digital Therapeutics. PulmoBioMed is a spinout with commercial potential and a wide range of diagnostic applications. They are a great fit with Onyx Health’s ethos and values as an agency and we feel we can offer them the greatest value from the £5,000 prize.”

PulmoBioMed Chief Operating Officer Jonathan Brookes added, "We’ve already had a flurry of interest in PBM-Hale™ and its range of clinical applications following our recent launch. We’ve gained recognition as a leading company in our field. Our key focus is on developing and commercialising the breath sampling technology and its integration into a range of healthcare settings. Onyx Health’s specialist healthcare communication knowledge will help us stand out from the crowd in a highly competitive market”.

27th April 2021

Share

Tags

Company Details

Onyx Health Ltd

01916403638

Contact Website

Address:
Hoults Yard
Walker Road
Newcastle upon Tyne
Tyne and Wear
NE6 1AB
United Kingdom

Latest content on this profile

PulmoBioMed Wins National Life Science Competition
Newly launched Northumbria University spinout PulmoBioMed has been handpicked as the winners of Onyx Health's ThinkBig competition
Onyx Health Ltd
Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics
Leading biotechnology company NovaBiotics Ltd have secured a major licensing deal for their fungal nail treatment
Onyx Health Ltd
Newcells Biotech secures over £5m for 3D tissue models
Newcells Biotech have received multi-million investment to develop their pioneering 3D tissue models
Onyx Health Ltd
Onyx Health Targets Digital Growth with New Executive Director
Healthcare marketing communications agency Onyx Health have appointed Trevor Pill as their new Executive Director
Onyx Health Ltd
Onyx Health Launch National Competition for Life Science SMEs
Healthcare marketing communications agency Onyx Health are launching a national competition #ThinkBig to help health and life sciences SMEs bounce back from the COVID-19 crisis
Onyx Health Ltd
Onyx Health Celebrates Its 10th Anniversary with Five New Hires
Onyx Health have marked their 10th anniversary by welcoming five new members to their rapidly expanding team. These appointments come on the back of the agency’s continued growth throughout the COVID-19 crisis
Onyx Health Ltd